VRAX

Virax Biolabs Group Limited - Ordinary Shares (VRAX)

About Virax Biolabs Group Limited - Ordinary Shares (VRAX)

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Details

Daily high
$1.05
Daily low
$0.95
Price at open
$1.04
52 Week High
$9.00
52 Week Low
$0.60
Market cap
4.3M
Dividend yield
0.00%
Volume
185,351
Avg. volume
306,334
P/E ratio
-.42

Virax Biolabs Group Limited - Ordinary Shares News

Details

Daily high
$1.05
Daily low
$0.95
Price at open
$1.04
52 Week High
$9.00
52 Week Low
$0.60
Market cap
4.3M
Dividend yield
0.00%
Volume
185,351
Avg. volume
306,334
P/E ratio
-.42